These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30559944)
1. Using left ventricular assist devices in advanced heart failure patients. Shah SR; Issa Najim N; Shah SA; Shahnawaz W; Ahmed Jangda M J Community Hosp Intern Med Perspect; 2018; 8(6):357-359. PubMed ID: 30559944 [TBL] [Abstract][Full Text] [Related]
2. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996 [TBL] [Abstract][Full Text] [Related]
3. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476 [TBL] [Abstract][Full Text] [Related]
4. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3. Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114 [TBL] [Abstract][Full Text] [Related]
5. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. Heatley G; Sood P; Goldstein D; Uriel N; Cleveland J; Middlebrook D; Mehra MR; J Heart Lung Transplant; 2016 Apr; 35(4):528-36. PubMed ID: 27044532 [TBL] [Abstract][Full Text] [Related]
6. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. Mehra MR; Naka Y; Uriel N; Goldstein DJ; Cleveland JC; Colombo PC; Walsh MN; Milano CA; Patel CB; Jorde UP; Pagani FD; Aaronson KD; Dean DA; McCants K; Itoh A; Ewald GA; Horstmanshof D; Long JW; Salerno C; N Engl J Med; 2017 Feb; 376(5):440-450. PubMed ID: 27959709 [TBL] [Abstract][Full Text] [Related]
10. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial. Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187 [TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist devices: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453 [TBL] [Abstract][Full Text] [Related]
12. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II? Florisson DS; Conte SM; De Bono JA; Newcomb AE Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825 [TBL] [Abstract][Full Text] [Related]
13. The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD). Chatterjee A; Feldmann C; Hanke JS; Ricklefs M; Shrestha M; Dogan G; Haverich A; Schmitto JD J Thorac Dis; 2018 Jun; 10(Suppl 15):S1790-S1793. PubMed ID: 30034854 [TBL] [Abstract][Full Text] [Related]
14. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange. Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698 [TBL] [Abstract][Full Text] [Related]
16. HeartMate left ventricular assist devices: a multigeneration of implanted blood pumps. Maher TR; Butler KC; Poirier VL; Gernes DB Artif Organs; 2001 May; 25(5):422-6. PubMed ID: 11403676 [TBL] [Abstract][Full Text] [Related]
17. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps. Zhang J; Chen Z; Griffith BP; Wu ZJ Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405 [TBL] [Abstract][Full Text] [Related]
18. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]